{"id":"https://openalex.org/W2016116513","doi":"https://doi.org/10.1002/ardp.200700216","title":"Synthesis and Anti\u2010HIV Activity Evaluation of Novel 2,4\u2010Disubstituted 7\u2010Methyl\u20101,1,3\u2010trioxo\u20102,4\u2010dihydro\u2010pyrazolo\u2010[4,5\u2010e][1,2]thiadiazines","display_name":"Synthesis and Anti\u2010HIV Activity Evaluation of Novel 2,4\u2010Disubstituted 7\u2010Methyl\u20101,1,3\u2010trioxo\u20102,4\u2010dihydro\u2010pyrazolo\u2010[4,5\u2010e][1,2]thiadiazines","publication_year":2008,"publication_date":"2008-02-12","ids":{"openalex":"https://openalex.org/W2016116513","doi":"https://doi.org/10.1002/ardp.200700216","mag":"2016116513","pmid":"https://pubmed.ncbi.nlm.nih.gov/18266290"},"language":"en","primary_location":{"id":"doi:10.1002/ardp.200700216","doi":"https://doi.org/10.1002/ardp.200700216","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ardp.200700216","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.200700216","source":{"id":"https://openalex.org/S174911965","display_name":"Archiv der Pharmazie","issn_l":"0365-6233","issn":["0365-6233","0376-0367","1521-4184"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archiv der Pharmazie","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.200700216","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059468550","display_name":"Xinyong Liu","orcid":"https://orcid.org/0000-0002-7302-2214","observed_orcids":["https://orcid.org/0000-0002-7302-2214","https://orcid.org/0000-0002-4898-7882","https://orcid.org/0009-0003-4120-6937"]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin\u2010yong Liu","raw_affiliation_strings":["Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, PR China. epalaska@hacettepe.edu.tr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, PR China. epalaska@hacettepe.edu.tr","institution_ids":["https://openalex.org/I154099455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113872568","display_name":"Renzhang Yan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ren\u2010zhang Yan","raw_affiliation_strings":["Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","institution_ids":["https://openalex.org/I154099455"]},{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264","institution_ids":["https://openalex.org/I154099455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322872","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0003-0671-7312","observed_orcids":["https://orcid.org/0000-0003-0671-7312","https://orcid.org/0000-0003-3934-9835","https://orcid.org/0009-0002-2442-7992","https://orcid.org/0000-0002-0379-9386"]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":["Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","institution_ids":["https://openalex.org/I154099455"]},{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264","institution_ids":["https://openalex.org/I154099455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081479819","display_name":"Peng Zhan","orcid":"https://orcid.org/0000-0002-9675-6026","observed_orcids":["https://orcid.org/0000-0002-9675-6026","https://orcid.org/0000-0002-7168-613X","https://orcid.org/0000-0001-7189-6244"]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng Zhan","raw_affiliation_strings":["Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China","institution_ids":["https://openalex.org/I154099455"]},{"raw_affiliation_string":"Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China. Fax: +86 531 8838-2264","institution_ids":["https://openalex.org/I154099455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040662398","display_name":"Erik De Clercq","orcid":"https://orcid.org/0000-0002-2985-8890","observed_orcids":["https://orcid.org/0000-0002-2985-8890"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Erik De Clercq","raw_affiliation_strings":["Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016741562","display_name":"Christophe C. Pannecouque","orcid":"https://orcid.org/0000-0002-1254-4473","observed_orcids":["https://orcid.org/0000-0002-1254-4473"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Christophe Pannecouque","raw_affiliation_strings":["Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066053312","display_name":"Myriam Witvrouw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Myriam Witvrouw","raw_affiliation_strings":["Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Rega Institute for Medical Research, Katholieke Universiteit Leuven,#R#Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076670892","display_name":"Mar\u00eda Teresa Molina","orcid":"https://orcid.org/0000-0003-0241-0196","observed_orcids":["https://orcid.org/0000-0003-0241-0196"]},"institutions":[{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I4210121842","display_name":"Instituto de Qu\u00edmica M\u00e9dica","ror":"https://ror.org/02vznxv75","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210121842"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Maria Teresa Molina","raw_affiliation_strings":["Instituto de Quimica Medica (CSIC), Madrid, Spain","Instituto De Qu\u00edmica M\u00e9dica, CSIC, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Quimica Medica (CSIC), Madrid, Spain","institution_ids":["https://openalex.org/I4210121842"]},{"raw_affiliation_string":"Instituto De Qu\u00edmica M\u00e9dica, CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I134820265","https://openalex.org/I4210121842"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109008802","display_name":"Salvador Vega","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134820265","display_name":"Consejo Superior de Investigaciones Cient\u00edficas","ror":"https://ror.org/02gfc7t72","country_code":"ES","type":"government","lineage":["https://openalex.org/I134820265"]},{"id":"https://openalex.org/I4210121842","display_name":"Instituto de Qu\u00edmica M\u00e9dica","ror":"https://ror.org/02vznxv75","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210121842"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Vega","raw_affiliation_strings":["Instituto de Quimica Medica (CSIC), Madrid, Spain","Instituto De Qu\u00edmica M\u00e9dica, CSIC, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto de Quimica Medica (CSIC), Madrid, Spain","institution_ids":["https://openalex.org/I4210121842"]},{"raw_affiliation_string":"Instituto De Qu\u00edmica M\u00e9dica, CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I134820265","https://openalex.org/I4210121842"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":0.6568,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.70562669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"341","issue":"4","first_page":"216","last_page":"222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.49799999594688416,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12410","display_name":"Structural and Chemical Analysis of Organic and Inorganic Compounds","score":0.1193000003695488,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.11429999768733978,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-hiv-activity","display_name":"anti-HIV activity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/hiv-1-replication-inhibition","display_name":"HIV-1 replication inhibition","score":0.6480000019073486},{"id":"https://openalex.org/keywords/mt-4-cells","display_name":"MT-4 cells","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antiviral-drug-design","display_name":"antiviral drug design","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9053367376327515},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6722230911254883},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5535154342651367},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.47038590908050537},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.32884424924850464},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.26248204708099365},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.181616872549057},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.11098164319992065},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003499","descriptor_name":"Cyclic S-Oxides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D003499","descriptor_name":"Cyclic S-Oxides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003588","descriptor_name":"Cytopathogenic Effect, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013055","descriptor_name":"Spectrophotometry, Infrared","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013829","descriptor_name":"Thiadiazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013829","descriptor_name":"Thiadiazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015498","descriptor_name":"HIV-2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ardp.200700216","doi":"https://doi.org/10.1002/ardp.200700216","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ardp.200700216","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.200700216","source":{"id":"https://openalex.org/S174911965","display_name":"Archiv der Pharmazie","issn_l":"0365-6233","issn":["0365-6233","0376-0367","1521-4184"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archiv der Pharmazie","raw_type":"journal-article"},{"id":"pmid:18266290","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18266290","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archiv der Pharmazie","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/ardp.200700216","doi":"https://doi.org/10.1002/ardp.200700216","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ardp.200700216","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.200700216","source":{"id":"https://openalex.org/S174911965","display_name":"Archiv der Pharmazie","issn_l":"0365-6233","issn":["0365-6233","0376-0367","1521-4184"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archiv der Pharmazie","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016116513.pdf","grobid_xml":"https://content.openalex.org/works/W2016116513.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2015559549","https://openalex.org/W2015696347","https://openalex.org/W2032571795","https://openalex.org/W2037716012","https://openalex.org/W2050747066","https://openalex.org/W2063825413","https://openalex.org/W2085313140","https://openalex.org/W2100543276","https://openalex.org/W2103894026","https://openalex.org/W2129368619","https://openalex.org/W2129793678","https://openalex.org/W2416661311","https://openalex.org/W2951881885"],"related_works":["https://openalex.org/W2092253669","https://openalex.org/W2322394655","https://openalex.org/W2950160248","https://openalex.org/W6949266209","https://openalex.org/W2951000717","https://openalex.org/W2058140305","https://openalex.org/W2031030565","https://openalex.org/W2011040666","https://openalex.org/W2073415505","https://openalex.org/W896551578"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,23,61],"novel":[3],"2,4-disubstituted":[4],"7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo[4,5-e]":[5],"[1,2,4]thiadiazines":[6],"(PTDs)":[7],"was":[8,48],"synthesized,":[9],"structurally":[10],"confirmed":[11],"by":[12,21],"spectral":[13],"analysis,":[14],"and":[15,64],"evaluated":[16],"for":[17,72],"their":[18],"anti-HIV":[19],"activities":[20],"inhibition":[22],"HIV-induced":[24],"cytopathogenicity":[25],"in":[26],"MT-4":[27],"cell":[28],"culture.":[29],"The":[30,43],"results":[31],"showed":[32],"that":[33],"some":[34],"compounds":[35],"exhibited":[36],"inhibitory":[37],"activity":[38],"specifically":[39],"against":[40],"HIV-2":[41,46],"replication.":[42],"most":[44],"active":[45],"inhibitor":[47],"compound":[49],"7i":[50],"(R1":[51],"=":[52,55],"benzyl,":[53],"R2":[54],"4-t-butyl-benzyl)":[56],"with":[57],"an":[58],"EC50":[59],"value":[60],"18.7":[62],"microM":[63],"SI=15,":[65],"which":[66],"may":[67],"provide":[68],"a":[69],"useful":[70],"lead":[71],"further":[73],"molecular":[74],"optimization.":[75]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}